About
TietAI (Tiet AI, S.L.) is a Madrid-based healthcare data integration company building Hydra, an AI-native interoperability platform unifying HL7, FHIR, DICOM, X12 and OMOP into a governed data plane for hospitals, payers and digital health.
Capital graph
Founders / team· 2
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- TietAI
TietAI (Tiet AI, S.L.) is a Madrid-based healthcare data integration company building Hydra, an AI-native interoperability platform unifying HL7, FHIR, DICOM, X12 and OMOP into a governed data plane for hospitals, payers and digital health.
—
United States
BusinessLatest roundTotal raisedDate- Datavant
Healthcare data collaboration platform: secure linkage, de-identification and exchange of medical records across institutions
$83M
$83M - Assort Health
Uses AI agents to automate patient intake at healthcare providers; covers 22 specialties and has handled more than 125 million patient interactions
Series C · $222M · 2026-06 · Valuation $1.2B
$222MValuation $1.2B - Nitra
AI-native operating system for healthcare providers, embedding AI agents in finance, commercial, inventory and patient management workflows
Series B · $100M · 2026-03
$100M
Europe
BusinessLatest roundTotal raisedDate- CiaoDott
Vertical AI voice platform for healthcare, supporting clinical communication and decision support for physicians and healthcare institutions
Pre-Seed · $2M · 2026-03
$2M - Tandem Health
AI clinical assistant for European healthcare providers: pre-visit summaries, real-time consultation transcription, and automatic post-visit generation of medical records and diagnostic codes
Series B · $160M · 2026-09
$160M - ReportAId
AI that interprets and extracts medical report data to help providers improve patient care, engagement and retention
Pre-Seed · $3M · 2025-05
$3M
Other / unspecified
BusinessLatest roundTotal raisedDate- Kraionyx AI
High-reliability medical AI agents for physicians and healthcare organizations: clinical decision support, ambient voice-to-clinical-notes, physician case collaboration network
— - Even Healthcare
Health subscription membership for individuals and businesses (unlimited consultations, free testing), with a company-operated network of hospitals and clinics and accompanying health insurance.
Series B · $120M · 2026-10 · Valuation $300M
$120MValuation $300M - Craif
Urine microRNA plus AI early cancer detection service (miSignal) and software medical device development for pancreatic cancer diagnosis
Series D+ · $88M · 2026-08
$88M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.